These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26684655)

  • 1. Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy.
    Pujol A
    Endocr Dev; 2016; 30():147-60. PubMed ID: 26684655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A paradigm for axonal degeneration.
    Fourcade S; Ferrer I; Pujol A
    Free Radic Biol Med; 2015 Nov; 88(Pt A):18-29. PubMed ID: 26073123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
    Baarine M; Beeson C; Singh A; Singh I
    J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Ruiz M; Ferrer I; Pujol A
    Biochimie; 2014 Mar; 98():143-9. PubMed ID: 24076127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?
    Galea E; Launay N; Portero-Otin M; Ruiz M; Pamplona R; Aubourg P; Ferrer I; Pujol A
    Biochim Biophys Acta; 2012 Sep; 1822(9):1475-88. PubMed ID: 22353463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
    Kruska N; Schönfeld P; Pujol A; Reiser G
    Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
    Singh J; Olle B; Suhail H; Felicella MM; Giri S
    J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
    Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.
    Fourcade S; Ruiz M; Guilera C; Hahnen E; Brichta L; Naudi A; Portero-Otín M; Dacremont G; Cartier N; Wanders R; Kemp S; Mandel JL; Wirth B; Pamplona R; Aubourg P; Pujol A
    Hum Mol Genet; 2010 May; 19(10):2005-14. PubMed ID: 20179078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.
    Ranea-Robles P; Launay N; Ruiz M; Calingasan NY; Dumont M; Naudí A; Portero-Otín M; Pamplona R; Ferrer I; Beal MF; Fourcade S; Pujol A
    EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29997171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency.
    Oezen I; Rossmanith W; Forss-Petter S; Kemp S; Voigtländer T; Moser-Thier K; Wanders RJ; Bittner RE; Berger J
    Hum Mol Genet; 2005 May; 14(9):1127-37. PubMed ID: 15772093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice.
    Netik A; Hobel A; Rauschka H; Molzer B; Forss-Petter S; Berger J
    J Inherit Metab Dis; 2000 Sep; 23(6):615-24. PubMed ID: 11032336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.
    Baarine M; Andréoletti P; Athias A; Nury T; Zarrouk A; Ragot K; Vejux A; Riedinger JM; Kattan Z; Bessede G; Trompier D; Savary S; Cherkaoui-Malki M; Lizard G
    Neuroscience; 2012 Jun; 213():1-18. PubMed ID: 22521832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
    Kemp S; Berger J; Aubourg P
    Biochim Biophys Acta; 2012 Sep; 1822(9):1465-74. PubMed ID: 22483867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.
    Asheuer M; Bieche I; Laurendeau I; Moser A; Hainque B; Vidaud M; Aubourg P
    Hum Mol Genet; 2005 May; 14(10):1293-303. PubMed ID: 15800013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophilin D as a potential target for antioxidants in neurodegeneration: the X-ALD case.
    López-Erauskin J; Ferrer I; Galea E; Pujol A
    Biol Chem; 2013 May; 394(5):621-9. PubMed ID: 23492556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy.
    Morató L; Galino J; Ruiz M; Calingasan NY; Starkov AA; Dumont M; Naudí A; Martínez JJ; Aubourg P; Portero-Otín M; Pamplona R; Galea E; Beal MF; Ferrer I; Fourcade S; Pujol A
    Brain; 2013 Aug; 136(Pt 8):2432-43. PubMed ID: 23794606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.